Centocor Inc, A Johnson & Johnson Company- Centocor utilizes cutting-edge knowledge in biotechnology to discover and develop innovative large and small molecule medicines. Centocor has a leadership position in monoclonal antibody technology. The company creates, acquires and markets unique biopharmaceutical therapies to aid patients in need. Centocor's innovative products focus on the management of three major disease areas; cardiovascular, immunologic disorders and cancer. AGIL Analysis - Centocor Integration More emphasis on Direct Sales and …showed first 75 words of 1549 total…

…showed last 75 words of 1549 total…through-put rate by 2006 of one new product launch every 18 months Adaptation Developing alliances/collaboration broadened focus on infectious-disease research development of high-value product franchises intellectual property - HIV research research and development of products for cancer patients - first mover AGIL Analysis - Chiron References Web site: http: //www.chiron.com Web site: http: //www.amgen.com Web site: http: //www.centocor.com Web site: http: //www.genzyme.com Web site: http: //www.genentech.com